Skip to main content

Table 2 Clinical parameters at baseline and after one week rinsing (reevaluation)

From: Efficacy of an aluminium triformate mouthrinse during the maintenance phase in periodontal patients: a pilot double blind randomized placebo-controlled clinical trial

Clinical parameter

ATF (n = 20)

Placebo (n = 20)

p-value (inter-group differences)

Primary outcome:

   

MSBI

Baseline

62.8 ± 17.1

59.2 ± 14.8

0.529

 

Reevaluation

45.2 ± 18.9

51.6 ± 19.5

0.383

 

p-value (intra-group differences)

0.001

0.018

 
 

Reduction

17.6 ± 13.8

7.6 ± 11.3

0.035

Secondary outcome:

   

PI

Baseline

0.7 ± 0.5

0.7 ± 0.4

0.640

 

Reevaluation

0.8 ± 0.5

0.7 ± 0.4

0.445

 

p-value (intra-group differences)

0.17

0.34

 
 

Reduction

0.09 ± 0.27

0.06 ± 0.26

0.947

API

Baseline

52.2 ± 19.1

43.3 ± 14.7

0.157

 

Reevaluation

57.3 ± 20.8

45.1 ± 15.9

0.056

 

p-value (intra-group differences)

0.177

0.602

 
 

Reduction

5.1 ± 14.9

1.8 ± 12.0

0.495

  1. Values represent descriptive means and standard deviations for all indices